Cargando…
Randomized controlled field trial to assess the efficacy of an intranasal Moraxella bovis cytotoxin vaccine against naturally occurring infectious bovine keratoconjunctivitis
BACKGROUND: Infectious bovine keratoconjunctivitis (IBK; pinkeye) is generally considered to be caused by corneal infections with Moraxella bovis. Previous studies demonstrated that M. bovis cytotoxin-specific mucosal immune responses in the bovine eye can be stimulated by intranasal vaccination wit...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10492207/ https://www.ncbi.nlm.nih.gov/pubmed/37693844 http://dx.doi.org/10.1016/j.jvacx.2023.100378 |
_version_ | 1785104202355179520 |
---|---|
author | Angelos, John A. Agulto, Regina L. Mandzyuk, Boguslav Chigerwe, Munashe |
author_facet | Angelos, John A. Agulto, Regina L. Mandzyuk, Boguslav Chigerwe, Munashe |
author_sort | Angelos, John A. |
collection | PubMed |
description | BACKGROUND: Infectious bovine keratoconjunctivitis (IBK; pinkeye) is generally considered to be caused by corneal infections with Moraxella bovis. Previous studies demonstrated that M. bovis cytotoxin-specific mucosal immune responses in the bovine eye can be stimulated by intranasal vaccination with a recombinant M. bovis cytotoxin subunit adjuvanted with polyacrylic acid. METHODS: A randomized controlled field trial (two-arm parallel design with blinding) was conducted in beef steers in Northern California to determine if this vaccine could prevent naturally occurring IBK and/or reduce morbidity rates associated with this disease. Beef steers were vaccinated intranasally on days 0 and 21 with either a recombinant M. bovis cytotoxin subunit adjuvanted with polyacrylic acid (Vaccine group) or adjuvant alone (Control group). Eye examinations were performed on all steers every 7 days for 16 weeks to document the occurrence of IBK and to determine sizes of corneal ulcers. Serum and tear samples were collected on days 0, 42, and 112 from a subset of animals to measure changes in systemic and ocular immune responses to M. bovis cytotoxin. RESULTS: The cumulative proportion of steers that developed IBK after 16 weeks did not differ between groups. Variables related to disease severity were numerically lower in steers that received the experimental vaccine. IBK-affected Vaccine group steers had a significantly lower number of observation weeks with severe ulcers versus Control group steers. Cytotoxin-specific tear IgA was significantly higher in Vaccine group compared to Control group steers on day 112. Conclusion: Although the proportion of animals that developed corneal ulcers associated with IBK did not differ between groups, the lowered metrics of disease severity in vaccinated steers suggests that intranasal vaccination with recombinant M. bovis cytotoxin can reduce the severity of IBK in cattle. |
format | Online Article Text |
id | pubmed-10492207 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Elsevier |
record_format | MEDLINE/PubMed |
spelling | pubmed-104922072023-09-10 Randomized controlled field trial to assess the efficacy of an intranasal Moraxella bovis cytotoxin vaccine against naturally occurring infectious bovine keratoconjunctivitis Angelos, John A. Agulto, Regina L. Mandzyuk, Boguslav Chigerwe, Munashe Vaccine X Regular paper BACKGROUND: Infectious bovine keratoconjunctivitis (IBK; pinkeye) is generally considered to be caused by corneal infections with Moraxella bovis. Previous studies demonstrated that M. bovis cytotoxin-specific mucosal immune responses in the bovine eye can be stimulated by intranasal vaccination with a recombinant M. bovis cytotoxin subunit adjuvanted with polyacrylic acid. METHODS: A randomized controlled field trial (two-arm parallel design with blinding) was conducted in beef steers in Northern California to determine if this vaccine could prevent naturally occurring IBK and/or reduce morbidity rates associated with this disease. Beef steers were vaccinated intranasally on days 0 and 21 with either a recombinant M. bovis cytotoxin subunit adjuvanted with polyacrylic acid (Vaccine group) or adjuvant alone (Control group). Eye examinations were performed on all steers every 7 days for 16 weeks to document the occurrence of IBK and to determine sizes of corneal ulcers. Serum and tear samples were collected on days 0, 42, and 112 from a subset of animals to measure changes in systemic and ocular immune responses to M. bovis cytotoxin. RESULTS: The cumulative proportion of steers that developed IBK after 16 weeks did not differ between groups. Variables related to disease severity were numerically lower in steers that received the experimental vaccine. IBK-affected Vaccine group steers had a significantly lower number of observation weeks with severe ulcers versus Control group steers. Cytotoxin-specific tear IgA was significantly higher in Vaccine group compared to Control group steers on day 112. Conclusion: Although the proportion of animals that developed corneal ulcers associated with IBK did not differ between groups, the lowered metrics of disease severity in vaccinated steers suggests that intranasal vaccination with recombinant M. bovis cytotoxin can reduce the severity of IBK in cattle. Elsevier 2023-09-01 /pmc/articles/PMC10492207/ /pubmed/37693844 http://dx.doi.org/10.1016/j.jvacx.2023.100378 Text en © 2023 The Authors https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/). |
spellingShingle | Regular paper Angelos, John A. Agulto, Regina L. Mandzyuk, Boguslav Chigerwe, Munashe Randomized controlled field trial to assess the efficacy of an intranasal Moraxella bovis cytotoxin vaccine against naturally occurring infectious bovine keratoconjunctivitis |
title | Randomized controlled field trial to assess the efficacy of an intranasal Moraxella bovis cytotoxin vaccine against naturally occurring infectious bovine keratoconjunctivitis |
title_full | Randomized controlled field trial to assess the efficacy of an intranasal Moraxella bovis cytotoxin vaccine against naturally occurring infectious bovine keratoconjunctivitis |
title_fullStr | Randomized controlled field trial to assess the efficacy of an intranasal Moraxella bovis cytotoxin vaccine against naturally occurring infectious bovine keratoconjunctivitis |
title_full_unstemmed | Randomized controlled field trial to assess the efficacy of an intranasal Moraxella bovis cytotoxin vaccine against naturally occurring infectious bovine keratoconjunctivitis |
title_short | Randomized controlled field trial to assess the efficacy of an intranasal Moraxella bovis cytotoxin vaccine against naturally occurring infectious bovine keratoconjunctivitis |
title_sort | randomized controlled field trial to assess the efficacy of an intranasal moraxella bovis cytotoxin vaccine against naturally occurring infectious bovine keratoconjunctivitis |
topic | Regular paper |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10492207/ https://www.ncbi.nlm.nih.gov/pubmed/37693844 http://dx.doi.org/10.1016/j.jvacx.2023.100378 |
work_keys_str_mv | AT angelosjohna randomizedcontrolledfieldtrialtoassesstheefficacyofanintranasalmoraxellaboviscytotoxinvaccineagainstnaturallyoccurringinfectiousbovinekeratoconjunctivitis AT agultoreginal randomizedcontrolledfieldtrialtoassesstheefficacyofanintranasalmoraxellaboviscytotoxinvaccineagainstnaturallyoccurringinfectiousbovinekeratoconjunctivitis AT mandzyukboguslav randomizedcontrolledfieldtrialtoassesstheefficacyofanintranasalmoraxellaboviscytotoxinvaccineagainstnaturallyoccurringinfectiousbovinekeratoconjunctivitis AT chigerwemunashe randomizedcontrolledfieldtrialtoassesstheefficacyofanintranasalmoraxellaboviscytotoxinvaccineagainstnaturallyoccurringinfectiousbovinekeratoconjunctivitis |